Literature DB >> 21222294

Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas: the role of the hypothalamus.

Guenther Christian Feigl1, Karin Pistracher, Andrea Berghold, Michael Mokry.   

Abstract

OBJECT: Causes of pituitary insufficiencies as a side effect of Gamma Knife surgery (GKS) following irradiation of the hypothalamopituitary axis are still under debate. In an investigation of pituitary insufficiencies after GKS, the authors' main focus is on what role can be attributed to the hypothalamus with regard to endocrinological changes in hypothalamopituitary function following GKS.
METHODS: A total of 108 patients consecutively treated between April 1992 and July 2003 were included in this retrospective study. All patients had undergone either transsphenoidal or transcranial surgery prior to GKS. The spot dosimetry method was used to determine doses delivered to structures of the hypothalamopituitary axis. For statistical analyses, endocrine insufficiency and deterioration in pituitary function were defined as a decrease in hormonal blood levels below the normal range for 1 or more anterior pituitary lobe hormones. Additionally, an analysis of the rate of patients requiring hormone replacement therapy after GKS due to new endocrinopathies was performed.
RESULTS: Complete patient records of 61 male and 47 female patients with a mean age of 51.9 years (range 9.1–81.2 years) were available for our investigation. The overall tumor control rate was 97% and the endocrinological cure rate was 61.2%. Mean treatment doses in patients with and without new endocrine insufficiencies (shown as with/without insufficiencies and followed by probability values) were as follows: 1.3/0.8 Gy to the hypothalamus(p = 0.2); 2.2/1.6 Gy to the median eminence (p = 0.1); 6.5/4.1 Gy to the pituitary stalk (p = 0.004); and 12.4/9.5Gy to the pituitary gland (p = 0.05). The median overall duration of follow-up after GKS was 6.7 years, with 84 patients(77.7%) whose follow-up was longer than 12 months. The median follow-up time after GKS in patients who developed a new pituitary dysfunction was 79.5 months (6.6 years, SD 3.8 years), and the median follow-up time inpatients with no new insufficiencies was 78.4 months (6.5 years, SD 4 years).
CONCLUSIONS: Gamma Knife surgery is a safe and effective treatment for patients with residual and recurrent pituitary adenomas. The rate of pituitary insufficiencies after GKS is still lower than that after conventional radiotherapy.Very low radiation doses are directed to the hypothalamus, and thus this structure does not play a major role in the development of pituitary insufficiencies after GKS. The results of this study show that patients in whom the pituitary stalk and pituitary gland receive a high mean point dose are more likely to develop pituitary insufficiencies after GKS than those who receive a lower dose. (DOI: 10.3171/2010.8.GKS10959).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21222294

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Gamma knife radiosurgery for clinically persistent acromegaly.

Authors:  Xiaomin Liu; Hideyuki Kano; Douglas Kondziolka; Kyung-Jae Park; Aditya Iyer; Ajay Niranjan; John C Flickinger; L Dade Lunsford
Journal:  J Neurooncol       Date:  2012-04-26       Impact factor: 4.130

Review 2.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

3.  Outcome of partially irradiated recurrent nonfunctioning pituitary macroadenoma by gamma knife radiosurgery.

Authors:  Chiung-Chyi Shen; Weir-Chiang You; Ming-Hsi Sun; Shinh-Dung Lee; Hsi-Kai Tsou; Yen-Ju Chen; Meei-Ling Sheu; Jason Sheehan; Hung-Chuan Pan
Journal:  J Neurooncol       Date:  2018-06-13       Impact factor: 4.130

4.  Outcome of radiotherapy for pituitary adenomas.

Authors:  Patricia Sebastian; Rajesh Balakrishnan; Bijesh Yadav; Subhashini John
Journal:  Rep Pract Oncol Radiother       Date:  2016-07-15

5.  Stereotactic radiosurgery in pituitary adenomas: long-term single institution experience and role of the hypothalamic-pituitary axis.

Authors:  Kita Sallabanda; Sergey Usychkin; Fernando Puebla; José C Bustos; José A Gutiérrez-Diaz; Carmen Peraza; César Beltrán; Hugo Marsiglia; José Samblás
Journal:  J Radiosurg SBRT       Date:  2011

6.  Gamma knife radiosurgery for Cushing's disease and Nelson's syndrome.

Authors:  Josef Marek; Jana Ježková; Václav Hána; Michal Kršek; Roman Liščák; Vilibald Vladyka; Ladislav Pecen
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

7.  Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.

Authors:  I Jonathan Pomeraniec; Hideyuki Kano; Zhiyuan Xu; Brandon Nguyen; Zaid A Siddiqui; Danilo Silva; Mayur Sharma; Hesham Radwan; Jonathan A Cohen; Robert F Dallapiazza; Christian Iorio-Morin; Amparo Wolf; John A Jane; Inga S Grills; David Mathieu; Douglas Kondziolka; Cheng-Chia Lee; Chih-Chun Wu; Christopher P Cifarelli; Tomas Chytka; Gene H Barnett; L Dade Lunsford; Jason P Sheehan
Journal:  J Neurosurg       Date:  2017-10-27       Impact factor: 5.115

8.  Hypopituitarism after Gamma Knife radiosurgery for pituitary adenomas: a multicenter, international study

Authors:  Diogo Cordeiro; Zhiyuan Xu; Gautam Mehta; Dale Ding; Mary Lee Vance; Hideyuki Kano; Nathaniel Sisterson; Huai-che Yang; Douglas Kondziolka; L. Dade Lunsford; David Mathieu; Gene Barnett; Veronica Chiang; John Lee; Penny Sneed; Yan-Hua Su; Cheng-chia Lee; Michal Krsek; Roman Liscak; Ahmed Nabeel; Amr El-Shehaby; Khaled Karim; Wael Reda; Nuria Martinez-Moreno; Roberto Martinez-Alvarez; Kevin Blas; Inga Grills; Kuei Lee; Mikulas Kosak; Christopher Cifarelli; Gennadiy Katsevman; Jason Sheehan
Journal:  J Neurosurg       Date:  2018-11-09       Impact factor: 5.408

9.  Effect of treatment modality on the hypothalamic-pituitary function of patients treated with radiation therapy for pituitary adenomas: hypothalamic dose and endocrine outcomes.

Authors:  Andrew Elson; Joseph Bovi; Kawaljeet Kaur; Diana Maas; Grant Sinson; Chris Schultz
Journal:  Front Oncol       Date:  2014-04-09       Impact factor: 6.244

10.  Long term toxicity and prognostic factors of radiation therapy for secreting and non-secreting pituitary adenomas.

Authors:  Stefan Rieken; Daniel Habermehl; Thomas Welzel; Angela Mohr; Katja Lindel; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2013-01-23       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.